Other Clinical Trial - Prasterone (DHEA) for the Treatment of Hypoactive

See also
Status	Clinical Trial	Phase
Completed	`NCT02430987` - Low Sexual Desire and Metabolic Syndrome	N/A
Completed	`NCT01432665` - Lybrido for Female Sexual Dysfunction	Phase 2
Terminated	`NCT00551785` - Surveillance Study of Women Taking Intrinsa®	Phase 4
Completed	`NCT03232801` - A Mindfulness-based Intervention for Older Women With Low Sexual Desire	N/A
Recruiting	`NCT04179734` - Role of the Melanocortin-4 Receptor in Hypoactive Sexual Desire Disorder	Phase 4
Terminated	`NCT02770768` - Effects of Flibanserin on the Pre- and Post-menopausal Female Brain	N/A
Completed	`NCT01235754` - Extension Study to Assess Persistence of Benefit of LibiGel for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)	Phase 3
Completed	`NCT00384046` - Testosterone Therapy in Naturally Menopausal Women With Low Sexual Desire Receiving Transdermal Estrogen	Phase 3
Completed	`NCT00331123` - Study of Transdermal Testosterone Patches in Surgically Menopausal Women With Low Libido	Phase 3
Recruiting	`NCT04943068` - A Phase 3, Bridging, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial to Evaluate the Efficacy and Safety of Subcutaneously Administered Bremelanotide in Premenopausal Women With Hypoactive Sexual Desire Disorder (With or Without Decreased Arousal)	Phase 3
Completed	`NCT03463707` - BP101 for Adults With Female Sexual Dysfunction	Phase 3
Completed	`NCT01208038` - Testosterone Patch's Effects on the Cardiovascular System and Libido	Phase 4
Completed	`NCT00657501` - Safety and Efficacy of LibiGel® for Treatment of Hypoactive Sexual Desire Disorder in Surgically Menopausal Women	Phase 3
Completed	`NCT04336891` - Effect of Testosterone Treatment on Clitoral Arteries' Hemodynamic Parameters.
Completed	`NCT01382719` - Bremelanotide in Premenopausal Women With Female Sexual Arousal Disorder and/or Hypoactive Sexual Desire Disorder	Phase 2
Recruiting	`NCT00916396` - Dehydroepiandrosterone (DHEA) Treatment in Women and Men Experiencing Hypoactive Sexual Desire Disorder	N/A
Completed	`NCT00338312` - Study of Transdermal Testosterone Patches in Naturally Menopausal Women With Low Libido	Phase 3
Completed	`NCT00034021` - Ginkgo Biloba: Antidepressant-Induced Sexual Dysfunction	Phase 2
Completed	`NCT00331214` - Study of Transdermal Testosterone Patches in Surgically Menopausal Women With Low Libido	Phase 3
Recruiting	`NCT02968342` - Role of Progesterone in Hypoactive Sexual Desire Disorder in Menopausal Women	Phase 4

NCT number	NCT03287232
Study type	Interventional
Source	EndoCeutics Inc.
Contact
Status	Completed
Phase	Phase 3
Start date	October 16, 2017
Completion date	July 22, 2019

Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms